AI channel feed

Ex­clu­sive: In­spired by Spin­raza, start­up rais­es $25M for can­cer drug tar­gets cre­at­ed by al­ter­na­tive RNA splic­ing

11 months ago
Financing

Mer­ck KGaA con­tin­ues AI drug dis­cov­ery deal spree with Bi­olo­jic De­sign 

11 months ago
Deals

Sanofi, Ope­nAI, For­ma­tion Bio an­nounce AI drug de­vel­op­ment part­ner­ship

11 months ago
Deals
R&D

AI biotech Ex­sci­en­tia to trim near­ly a quar­ter of work­force, fol­low­ing pipeline cut and CEO fir­ing

11 months ago
People

The End­points Slack in­ter­view: Sid­dhartha Mukher­jee on the doc­tor-writer world­view, AI, and the fu­ture of can­cer

12 months ago
R&D
In Focus

Ex­clu­sive: Har­vard start­up rais­es $26M, strikes three phar­ma part­ner­ships for AI an­ti­body de­sign

12 months ago
Deals

'Big­ger, faster, bet­ter': Iso­mor­phic, Deep­Mind un­veil Al­phaFold 3, go­ing be­yond pro­tein pre­dic­tions

Last year
R&D

The next gen­er­a­tion of AI biotechs is here. Can they de­liv­er on the hype?

Last year
R&D

Ex­clu­sive: Marc Tessier-Lav­i­gne on leav­ing Stan­ford and join­ing biotech’s new AI mega-start­up

Last year
People
Startups

Why VC leg­end Bob Nelsen is mak­ing the biggest ini­tial bet of his 37-year ca­reer on Xaira

Last year
People
Startups

AI drug dis­cov­ery start­up Benev­o­len­tAI cuts 30% of staff, clos­es US of­fice 

Last year
People

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Last year
Pharma

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

Last year
R&D
In Focus

Ex­clu­sive: Ex-Re­cur­sion team launch­es Leash Bio, chal­leng­ing AI field with its bet on need­ing more da­ta

Last year
Financing

ARPA-H calls on AI de­vel­op­ers to help tack­le cy­ber­at­tacks

Last year
FDA+
Health Tech

Ex­clu­sive: ‘If you could hal­lu­ci­nate a pro­tein’: Proflu­ent snags $35M for gen­er­a­tive AI mod­els

Last year
Financing
Startups

David Bak­er’s lab shows gen­er­a­tive AI can de­sign an­ti­bod­ies. But are they good enough to be­come drugs?

Last year
R&D

‘An AI foundry’: Nvidia’s Jensen Huang pitch­es biotech on easy AI, with fo­cus on soft­ware go­ing be­yond chips

Last year

No­vo Nordisk Foun­da­tion backs ef­fort to build su­per­com­put­er with Nvidia

Last year
R&D

FDA lays out cross-agency ef­forts on reg­u­lat­ing AI in med­ical prod­ucts

Last year
Pharma
FDA+

Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

Last year
Financing
Startups

David Bak­er's lab re­leas­es new pro­tein de­sign and study tools as AI race ac­cel­er­ates

Last year
R&D
Discovery

Health tech in­vestors out­line in­vest­ment pri­or­i­ties in AI

Last year
Health Tech

Biden ad­min­is­tra­tion in­vests $48M in AI/ML plat­form to iden­ti­fy rare dis­ease drugs

Last year
Pharma
FDA+
First page Previous page 2345678 Next page Last page
A service from the Financial Times